These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1032 related articles for article (PubMed ID: 11166000)
1. Helicobacter pylori and nonsteroidal anti-inflammatory drugs: interaction with proton pump inhibitor therapy for prevention of nonsteroidal anti-inflammatory drug ulcers and ulcer complications--future research needs. Graham DY Am J Med; 2001 Jan; 110(1A):58S-61S. PubMed ID: 11166000 [TBL] [Abstract][Full Text] [Related]
2. Critical effect of Helicobacter pylori infection on the effectiveness of omeprazole for prevention of gastric or duodenal ulcers among chronic NSAID users. Graham DY Helicobacter; 2002 Feb; 7(1):1-8. PubMed ID: 11886469 [TBL] [Abstract][Full Text] [Related]
3. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding. Leontiadis GI; Sreedharan A; Dorward S; Barton P; Delaney B; Howden CW; Orhewere M; Gisbert J; Sharma VK; Rostom A; Moayyedi P; Forman D Health Technol Assess; 2007 Dec; 11(51):iii-iv, 1-164. PubMed ID: 18021578 [TBL] [Abstract][Full Text] [Related]
4. Omeprazole. A review of its use in Helicobacter pylori infection, gastro-oesophageal reflux disease and peptic ulcers induced by nonsteroidal anti-inflammatory drugs. Langtry HD; Wilde MI Drugs; 1998 Sep; 56(3):447-86. PubMed ID: 9777317 [TBL] [Abstract][Full Text] [Related]
5. Role of Helicobacter pylori in ulcer healing and recurrence of gastric and duodenal ulcers in longterm NSAID users. Response to omeprazole dual therapy. Bianchi Porro G; Parente F; Imbesi V; Montrone F; Caruso I Gut; 1996 Jul; 39(1):22-6. PubMed ID: 8881802 [TBL] [Abstract][Full Text] [Related]
6. Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs: results of a double-blind, randomized, multicenter, active- and placebo-controlled study of misoprostol vs lansoprazole. Graham DY; Agrawal NM; Campbell DR; Haber MM; Collis C; Lukasik NL; Huang B; Arch Intern Med; 2002 Jan; 162(2):169-75. PubMed ID: 11802750 [TBL] [Abstract][Full Text] [Related]
7. Use of proton-pump inhibitors in complicated ulcer disease and upper gastrointestinal tract bleeding. Howden CW Am J Health Syst Pharm; 1999 Dec; 56(23 Suppl 4):S5-11. PubMed ID: 10597118 [TBL] [Abstract][Full Text] [Related]
8. Influence of sex and Helicobacter pylori on development and healing of gastroduodenal lesions in non-steroidal anti-inflammatory drug users. Hawkey CJ; Wilson I; Naesdal J; Långström G; Swannell AJ; Yeomans ND Gut; 2002 Sep; 51(3):344-50. PubMed ID: 12171954 [TBL] [Abstract][Full Text] [Related]
9. Superiority of lansoprazole vs ranitidine in healing nonsteroidal anti-inflammatory drug-associated gastric ulcers: results of a double-blind, randomized, multicenter study. NSAID-Associated Gastric Ulcer Study Group. Agrawal NM; Campbell DR; Safdi MA; Lukasik NL; Huang B; Haber MM Arch Intern Med; 2000 May; 160(10):1455-61. PubMed ID: 10826458 [TBL] [Abstract][Full Text] [Related]
10. New data on healing of nonsteroidal anti-inflammatory drug-associated ulcers and erosions. Omeprazole NSAID Steering Committee. Yeomans ND Am J Med; 1998 Mar; 104(3A):56S-61S; discussion 79S-80S. PubMed ID: 9572322 [TBL] [Abstract][Full Text] [Related]
11. Current approaches to reducing gastrointestinal toxicity of low-dose aspirin. Lanas AI Am J Med; 2001 Jan; 110(1A):70S-73S. PubMed ID: 11166003 [TBL] [Abstract][Full Text] [Related]
12. Prevention of nonsteroidal anti-inflammatory drug-induced gastroduodenal ulcers: role of mucosal protective and gastric antisecretory drugs. Dajani EZ; Agrawal NM Dig Dis; 1995 Jan; 13 Suppl 1():48-61. PubMed ID: 7697902 [TBL] [Abstract][Full Text] [Related]
13. Does eradication of Helicobacter pylori impair healing of nonsteroidal anti-inflammatory drug associated bleeding peptic ulcers? A prospective randomized study. Chan FK; Sung JJ; Suen R; Lee YT; Wu JC; Leung WK; Chan HL; Lai AC; Lau JY; Ng EK; Chung SC Aliment Pharmacol Ther; 1998 Dec; 12(12):1201-5. PubMed ID: 9882027 [TBL] [Abstract][Full Text] [Related]
14. Helicobacter pylori infection and the use of NSAIDs. Bazzoli F; De Luca L; Graham DY Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):775-85. PubMed ID: 11566040 [TBL] [Abstract][Full Text] [Related]
15. Management of nonsteroidal anti-inflammatory drug-induced gastroduodenal disease by acid suppression. Lad R; Armstrong D Can J Gastroenterol; 1999 Mar; 13(2):135-42. PubMed ID: 10203432 [TBL] [Abstract][Full Text] [Related]
16. Relative contribution of mucosal injury and Helicobacter pylori in the development of gastroduodenal lesions in patients taking non-steroidal anti-inflammatory drugs. Hawkey CJ; Naesdal J; Wilson I; Långström G; Swannell AJ; Peacock RA; Yeomans ND Gut; 2002 Sep; 51(3):336-43. PubMed ID: 12171953 [TBL] [Abstract][Full Text] [Related]
17. Prophylaxis and treatment of non-steroidal anti-inflammatory drug-induced upper gastrointestinal side-effects. Lazzaroni M; Bianchi Porro G Dig Liver Dis; 2001 Dec; 33 Suppl 2():S44-58. PubMed ID: 11827362 [TBL] [Abstract][Full Text] [Related]
18. Progress in prophylaxis against nonsteroidal anti-inflammatory drug-associated ulcers and erosions. Omeprazole NSAID Steering Committee. Hawkey CJ Am J Med; 1998 Mar; 104(3A):67S-74S; discussion 79S-80S. PubMed ID: 9572324 [TBL] [Abstract][Full Text] [Related]
19. Does adding misoprostol to standard intravenous proton pump inhibitor protocol improve the outcome of aspirin/NSAID-induced upper gastrointestinal bleeding?: a randomized prospective study. Yilmaz S; Bayan K; Dursun M; Canoruç F; Kilinç N; Tüzün Y; Daniş R; Ertem M Dig Dis Sci; 2007 Jan; 52(1):110-8. PubMed ID: 17151802 [TBL] [Abstract][Full Text] [Related]
20. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications. Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]